RHÃN-KLINIKUM AG / Issue of Debt
04.03.2010 18:30
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Not for publication or distribution to US persons or in the USA or any
other jurisdiction in which offers or sales of securities of RHÃN-KLINIKUM
AG are prohibited by law.
RHÃN-KLINIKUM AG today successfully issued a bond (ISIN XS0491047154) with
a volume of
EUR 400,000,000 and a maturity of six years. The coupon of the bond is
3.875%, and the issue price was fixed at 99.575%. The bond is being offered
with a denomination of EUR 1,000. The issue proceeds will be used to
refinance existing financial liabilities as well as for general corporate
purposes.
For the execution of the transaction, Credit Suisse Securities (Europe)
Limited, UniCredit Bank AG and WestLB AG were appointed as joint
bookrunners. Prior to the transaction, RHÃN-KLINIKUM AG conducted a
roadshow where it met approx. 100 investors in Germany, Austria,
Switzerland and the UK.
The bond was more than 12 times oversubscribed. As a result of this
significant oversubscription, the spread was fixed at 125 bps which was
slightly below the initial spread guidance of 130 to 135 bps. In total,
some 350 investors from more than 25 countries subscribed. By region,
demand was focused on Germany (39%), UK/Ireland (23%) and
Austria/Switzerland (14%). More than 50% was placed with fund managers,
approx. 35% with banks, savings banks and Volksbanken as well as 6% with
insurers.
'With this bond transaction in the international capital market, we have
noticeably broadened our financing and investor base. The high demand for
our bond underscores RHÃN-KLINIKUM AG's special standing and leading role
in the capital market', explained Wolfgang Pföhler, chairman of the Board
of Management of RHÃN-KLINIKUM AG.
RHÃN-KLINIKUM AG is rated Baa2 by Moody's with a stable outlook.
These materials are not for distribution, directly or indirectly, in or
into the United States of America (including its territories and
dependencies, any State of the United States of America and the District of
Columbia).
These materials do not constitute or form part of any offer or solicitation
to purchase or subscribe for securities.
The bonds of RHÃN-KLINIKUM AG mentioned herein may not be offered or sold
within the United States of America or to US persons unless they are
registered or exempted from the registration obligation in accordance with
the U.S. Securities Act of 1933 in its version as amended (the 'Securities
Act'). The bonds have not been, and will not be, registered under the
Securities Act and will not be offered, sold or delivered in the United
States of America. The bonds are subject, inter alia, to US tax law.
Boris Tramm
Head of Investor Relations
Tel.: (09771) 65-1318 Fax: (09771) 65-1736
E-mail: boris.tramm@rhoen-klinikum-ag.com
Esther Walter
Head of Group Press and Public Relations
Tel.: (09771) 65 - 1322 Fax: (09771) 65 - 1820
E-mail: esther.walter@rhoen-klinikum-ag.com
04.03.2010 18:30 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|]
---------------------------------------------------------------------------
Language: English
Company: RHÃN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-News: RHÃN-KLINIKUM AG: RHÃN-KLINIKUM AG WITH SUCCESSFUL BOND TRANSACTION
| Source: EQS Group AG